MedTrace Logo

Feeding Intolerance in Formula-Fed Infants

NCT02028156 · Status: TERMINATED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 3

Last updated 2014-11-07

No results posted yet for this study

Summary

This is a non-randomized, single-group, multi-center, two phased study to evaluate formula intolerance.

Conditions

  • Feeding Intolerance

Interventions

OTHER

Partially Hydrolyzed Infant Formula

Commercially available infant formula

Sponsors & Collaborators

  • Abbott Nutrition

    lead INDUSTRY

Principal Investigators

  • Shirley Li, MD · Abbott Nutrition China

Study Design

Allocation
NA
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Max Age
60 Days
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2014-01-31
Primary Completion
2014-08-31
Completion
2014-08-31

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02028156 on ClinicalTrials.gov